Clinical Trials Sponsored by Aravive Biologics Inc

Total 229 results

Aravive, Inc.

Terminated

Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Clear Cell Renal Cell Carcinoma

United States
Aravive, Inc.

Completed

Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer

Ovarian Cancer

United States
M.D. Anderson Cancer Center
AstraZeneca; Aravive Biologics Inc

Active, not recruiting

AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma | Refractory Fallopian Tube... and other conditions

United States
Aravive, Inc.

Terminated

Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
Aravive, Inc.

Terminated

Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy

IgA Nephropathy

United States, Ukraine
Aravive, Inc.

Completed

A Phase 1 AVB-S6-500 Safety and Tolerability Study

Healthy Volunteer

United States
Versartis Inc.

Terminated

Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)

Growth Disorders | Pediatric Growth Hormone Deficiency

Japan
Versartis Inc.

Completed

Long-Acting Growth Hormone in Children Compared to Daily rhGH (VELOCITY)

Growth Disorders
Versartis Inc.

Completed

Versartis Trial in Children to Assess Long-Acting Growth Hormone (VERTICAL)

Pediatric Growth Hormone Deficiency

United States
Carevive Systems, Inc.

Recruiting

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Breast Cancer | Multiple Myeloma | Ovarian Cancer | Lung Cancer | Acute Myelogenous Leukemia

United States
Carevive Systems, Inc.

Completed

Integrating Geriatric Assessment for Older Patients Diagnosed With Acute Myelogenous Leukemia

Acute Myeloid Leukemia

United States
Carevive Systems, Inc.

Completed

Improving the Quality of Multiple Myeloma Treatment With Patient Care Plans

Multiple Myeloma
Carevive Systems, Inc.

Completed

Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning

Breast Cancer

United States
University of Oklahoma
EMD Serono; Aravive, Inc.

Active, not recruiting

Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma (COAXIN)

Urothelial Carcinoma

United States
Versartis Inc.
Premier Research Group plc

Completed

Versartis International Trial in Adults With Long-Acting Growth Hormone (VITAL)

Adult Growth Hormone Deficiency

United States, Australia, Germany, United Kingdom
Versartis Inc.
Premier Research Group plc

Terminated

Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)

Adult Growth Hormone Deficiency (AGHD)
Carevive Systems, Inc.

Recruiting

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Breast Cancer | Multiple Myeloma | Ovarian Cancer | Lung Cancer | Acute Myelogenous Leukemia

United States
Carevive Systems, Inc.

Completed

Use of a Patient Preferences Shared Decision-Making Encounter Tool in Clinical Practice for Patients With DLBCL and FL

Follicular Lymphoma | Diffuse Large B Cell Lymphoma

United States
Carevive Systems, Inc.

Completed

Shared Decision Making in Pain Management Planning in Patients With Cancer

Cancer

United States
Carevive Systems, Inc.

Completed

Chronic Lymphocytic Leukemia Electronic Patient Reported Outcomes Study

CLL

United States
Carevive Systems, Inc.

Recruiting

Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring

Breast Cancer | Multiple Myeloma | Lung Cancer | Gastrointestinal Cancer

United States
Carevive Systems, Inc.

Completed

Improving Cancer Outcomes Through Personalized Care Planning and Symptom Management.

Breast Cancer | Gynecologic Cancer | Lung Cancer

United States
Carevive Systems, Inc.

Completed

Understanding Evidence-Based Practice Patterns in Advanced NSCLC

Non Small Cell Lung Cancer

United States
Carevive Systems, Inc.

Withdrawn

Metastatic Breast Cancer Treatment Planning

Metastatic Breast Cancer
Carevive Systems, Inc.

Completed

Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma

Multiple Myeloma

United States
CanSino Biologics Inc.

Recruiting

A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)

Pertussis | Tetanus | Diphtheria

China
CanSino Biologics Inc.

Active, not recruiting

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population

Epidemic Meningitis

China
VIVEX Biologics, Inc.

Terminated

Wound Healing Following Penile Prosthesis Implant

Erectile Dysfunction

United States
CanSino Biologics Inc.

Active, not recruiting

Clinical Trial of Recombinant Pneumococcal Protein Vaccine

Respiratory Tract Infections | Respiratory Tract Diseases | Pneumonia

China
CanSino Biologics Inc.

Active, not recruiting

Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

COVID-19

China
CanSino Biologics Inc.

Completed

IH Convidecia as Second Booster Dose Against Breakthrough Infections

COVID-19

Malaysia
Aziyo Biologics, Inc.

Completed

CorMatrix ECM for Carotid Repair Following Endarterectomy Registry

Carotid Stenosis

United States
Aziyo Biologics, Inc.

Completed

Retrospective Experience Of CIED Implantation

Coronary Artery Disease | Heart Failure | Cardiac Disease

United States
Aziyo Biologics, Inc.

Completed

A Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction (PERFORM)

Peripheral Vascular Disease
Aziyo Biologics, Inc.

Withdrawn

CIED Implantation in Low BMI Patients

Heart Diseases | Cardiac Disease
Aziyo Biologics, Inc.

Withdrawn

A Study to Obtain Additional Information on the Use of CorMatrix® CanGaroo ECM® Envelope (JUMP)

Coronary Disease
Aziyo Biologics, Inc.

Withdrawn

A Study Evaluating 3-Level OLIF Spine Fusion

Degenerative Disc Disease | Spondylolisthesis | Retrolisthesis
CanSino Biologics Inc.

Withdrawn

A Study to Evaluate the Safety and Immunogenicity of Ad5-vector Based Vaccine Against Coronavirus Variants in Adults (≥18 Years) Immunized With 2 Doses of mRNA Vaccines Plus One Dose of Booster AZD1222 Vaccine

COVID-19
Qu Biologics Inc.

Terminated

QBECO SSI for Clinical and Endoscopic Remission in Moderate to Severe Crohn's Disease

Crohn Disease

Canada
Synthetic Biologics Inc.

Completed

A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an Ileostomy

Healthy Volunteers With Ileostomy

Canada
Precision Biologics, Inc

Completed

QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer

Metastatic Colorectal Cancer | Metastatic Pancreatic Cancer

United States
Qu Biologics Inc.

Completed

Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease

Crohn's Disease | Inflammatory Bowel Disease

Canada
MLM Biologics Inc.,

Unknown

Bio-ConneKt Wound Dressing for Treatment of Chronic Leg Wounds: A Pilot Study

Skin Ulcer
Pinnacle Biologics Inc.

Withdrawn

Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light

Esophageal Cancer | Non Small Cell Lung Cancer | High-grade Dysplasia in Barrett Esophagus
Pinnacle Biologics Inc.

Withdrawn

Safety of Photodynamic Therapy (PDT) in the Ablation of High-grade Dysplasia (HGD) in Barrett's Esophagus (BE) (Oedisse)

Barrett Esophagus
Forge Biologics, Inc

Not yet recruiting

Long-term Follow-up Study to Evaluate Safety and Efficacy of FBX-101 in Krabbe Patients

Krabbe Disease
CanSino Biologics Inc.

Not yet recruiting

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds

Meningococcal Meningitis
CanSino Biologics Inc.

Recruiting

A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

Tetanus

China
VIVEX Biologics, Inc.

Recruiting

Via Disc Nucleus Pulposus Older Patients Pilot

Low Back Pain | Degenerative Disc Disease | Disc Degeneration

United States
Forge Biologics, Inc

Active, not recruiting

Gene Transfer Clinical Trial for Krabbe Disease (RESKUE)

Krabbe Disease

United States

3

Subscribe